Penobscot Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98M Sell
16,503
-453
-3% -$155K 0.41% 64
2026
Q1
$5.97M Buy
16,956
+572
+3% +$204K 0.47% 55
2025
Q4
$5.36M Sell
16,384
-400
-2% -$127K 0.4% 58
2025
Q3
$4.74M Buy
16,784
+79
+0.5% +$22.9K 0.36% 65
2025
Q2
$4.66M Buy
16,705
+663
+4% +$188K 0.4% 59
2025
Q1
$5M Sell
16,042
-216
-1% -$63.8K 0.47% 54
2024
Q4
$4.24M Sell
16,258
-155
-0.9% -$46K 0.38% 60
2024
Q3
$5.29M Buy
16,413
+297
+2% +$97.2K 0.48% 53
2024
Q2
$5.04M Sell
16,116
-340
-2% -$99.9K 0.49% 49
2024
Q1
$4.68M Sell
16,456
-2,390
-13% -$699K 0.49% 52
2023
Q4
$5.43M Sell
18,846
-221
-1% -$60.2K 0.64% 43
2023
Q3
$5.12M Buy
19,067
+846
+5% +$211K 0.7% 40
2023
Q2
$4.05M Sell
18,221
-765
-4% -$178K 0.66% 44
2023
Q1
$4.59M Sell
18,986
-38
-0.2% -$9.33K 0.8% 36
2022
Q4
$5M Sell
19,024
-215
-1% -$57.6K 0.88% 34
2022
Q3
$4.34M Sell
19,239
-30
-0.2% -$7.27K 0.81% 33
2022
Q2
$4.69M Buy
19,269
+77
+0.4% +$18.9K 0.81% 37
2022
Q1
$4.64M Sell
19,192
-1,885
-9% -$433K 0.68% 43
2021
Q4
$4.74M Sell
21,077
-2,889
-12% -$610K 0.64% 45
2021
Q3
$5.1M Sell
23,966
-7,324
-23% -$1.69M 0.76% 38
2021
Q2
$7.63M Sell
31,290
-2,682
-8% -$660K 1.13% 29
2021
Q1
$8.45M Buy
33,972
+247
+0.7% +$58.9K 1.34% 25
2020
Q4
$7.75M Buy
33,725
+642
+2% +$148K 1.3% 26
2020
Q3
$8.41M Buy
33,083
+299
+0.9% +$74.1K 1.59% 19
2020
Q2
$7.73M Sell
32,784
-254
-0.8% -$58K 1.59% 19
2020
Q1
$6.7M Buy
33,038
+1,563
+5% +$341K 1.58% 17
2019
Q4
$7.59M Buy
31,475
+858
+3% +$189K 1.42% 18
2019
Q3
$5.92M Buy
30,617
+465
+2% +$89.3K 1.18% 27
2019
Q2
$5.56M Buy
30,152
+671
+2% +$120K 1.14% 28
2019
Q1
$5.6M Buy
29,481
+845
+3% +$161K 1.19% 26
2018
Q4
$5.57M Buy
28,636
+810
+3% +$158K 1.34% 21
2018
Q3
$5.77M Buy
27,826
+395
+1% +$77.8K 1.25% 22
2018
Q2
$5.06M Buy
27,431
+150
+0.5% +$26.5K 1.18% 23
2018
Q1
$4.65M Buy
27,281
+946
+4% +$174K 1.12% 24
2017
Q4
$4.58M Buy
26,335
+1,565
+6% +$277K 1.27% 22
2017
Q3
$4.62M Buy
24,770
+780
+3% +$138K 1.38% 17
2017
Q2
$4.13M Buy
23,990
+1,490
+7% +$242K 1.33% 22
2017
Q1
$3.69M Buy
22,500
+140
+0.6% +$23.3K 1.24% 25
2016
Q4
$3.27M Buy
22,360
+430
+2% +$64.7K 1.13% 28
2016
Q3
$3.66M Buy
21,930
+2,215
+11% +$375K 1.29% 24
2016
Q2
$3M Buy
19,715
+1,820
+10% +$283K 1.07% 32
2016
Q1
$2.68M Buy
17,895
+3,160
+21% +$469K 1% 33
2015
Q4
$2.39M Buy
14,735
+1,783
+14% +$280K 0.75% 45
2015
Q3
$1.79M Buy
12,952
+800
+7% +$126K 0.6% 53
2015
Q2
$1.87M Buy
12,152
+2,040
+20% +$327K 0.58% 60
2015
Q1
$1.62M Buy
10,112
+1,505
+17% +$237K 0.51% 62
2014
Q4
$1.37M Buy
8,607
+85
+1% +$13.2K 0.43% 74
2014
Q3
$1.2M Buy
8,522
+1,160
+16% +$151K 0.4% 76
2014
Q2
$872K Buy
7,362
+1,770
+32% +$205K 0.29% 85
2014
Q1
$690K Buy
5,592
+485
+9% +$58.8K 0.24% 93
2013
Q4
$582K Buy
5,107
+950
+23% +$108K 0.21% 100
2013
Q3
$466K Buy
4,157
+70
+2% +$7.59K 0.18% 109
2013
Q2
$404K Buy
+4,087
New +$424K 0.17% 114

Other funds holding AMGN

Penobscot Investment Management's AMGN Position: Q2 2026 in Review

Penobscot Investment Management reduced its Amgen (AMGN) stake by 2.7% in Q2 2026, selling an estimated $155K and leaving 16,503 shares worth $5.98M. The position accounts for 0.41% of the portfolio, ranked #64.

Penobscot Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.45M in Q1 2021. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Penobscot Investment Management held 16,503 shares of Amgen worth $5.98M as of Q2 2026.
  • Penobscot Investment Management sold 453 Amgen shares in Q2 2026, an estimated $155K.
  • Amgen made up 0.41% of Penobscot Investment Management's portfolio in Q2 2026, its #64 holding.
  • Penobscot Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Penobscot Investment Management's Amgen position peaked at $8.45M in Q1 2021.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.